Fecal Microbiota Transplantation (FMT) for Depression Therapy
News Release, International Society of Microbiota – March 14, 2022.
Depression is a debilitating disorder, and at least one third of patients do not respond to therapy. Associations between gut microbiota and depression have been observed in recent years, opening novel treatment avenues.
Dr. Schmidt presents a research portraying the first two patients with major depressive disorder ever treated with fecal microbiota transplantation as add-on therapy.
According to this study findings, both patients' depressive symptoms were improved 4 weeks after the transplantation and effects lasted up to 8 weeks in one patient. Moreover, gastrointestinal symptoms, constipation in particular, were reflected in microbiome changes and improved in one patient.
Interestingly, this reseach suggests that further FMT studies in depression could be worth pursuing and adds to awareness as well as safety assurance, both crucial in determining the potential of FMT in depression treatment.
Stay up-to-date on Microbiota Research, benefits, and recent discoveries through the Targeting Microbiota 2022 Congress.
In this congress, a special session will be dedicated to Strategies, Innovations & Challenges to Target Microbiota Dysbiosis. During this session, Prof. Peter Konturek will shed the light on FMT.
Media contact:
International Society of Microbiota
microbiota@microbiota-ism.com
Targeting Microbiota 2022 Congress
October 19-21, 2022 - Paris, France
www.microbiota-site.com
